...
首页> 外文期刊>Orthopaedic Journal of Sports Medicine >Meniscal Allograft Transplantation Reoperation Rates, Operative Findings, and Survival Analysis: A Review of 200 Consecutive Transplants at Minimum Two-year Follow-up
【24h】

Meniscal Allograft Transplantation Reoperation Rates, Operative Findings, and Survival Analysis: A Review of 200 Consecutive Transplants at Minimum Two-year Follow-up

机译:半月板同种异体移植的再手术率,手术结果和生存分析:在至少两年的随访中回顾了200例连续移植

获取原文
           

摘要

Objectives: Reoperation rates for meniscal allograft surgery (MAT) are high with a 70% survival rate at 10 years. The indications and findings for secondary surgery are not well characterized. The purpose of this study is to quantify the percentage of transplants requiring a re-operation, to characterize the operative findings, perform a survival analysis, and perform a case-control analysis if an early return to surgery is predictive of failure. Methods: A retrospective review of prospectively collected data from a single-surgeon was performed. Inclusion period was 2003-2011.. The number of patients returning to the OR and the findings at surgery were recorded. A meniscal transplant survival curve, the duration between transplantation and return to OR, and an odds-ratio of risk for failure for those requiring a re-operation in the perioperative period were calculated. Results: Two hundred patients underwent a MAT during the study period. 38% were isolated; 62% had concomitant procedures. Sixty-four (32%) patients returned to the operating room, of which 38 (59%) were for a meniscal? debridement. The mean duration to secondary surgery was 21 months, with 73% within 2 years. One hundred seventy-two (86%) patients were evaluated at a mean 59 months (Range 24-118 months). Eight went on to require a revision MAT or total knee replacement (4.7%). Patients requiring secondary surgery within two years had an 8.4 odds-ratio for future failure (95% CI 1.6-43.4 p.007). Conclusion: In the largest consecutive series reported in the literature, meniscal allograft transplantation (MAT) has a 95% success rate a mean of approximately five years. There is a 32% reoperation rate, with meniscal debridement the most common secondary surgical treatment.
机译:目的:半月板同种异体移植术(MAT)的再手术率很高,在10年时的存活率为70%。二次手术的适应症和发现尚未很好地表征。这项研究的目的是量化需要再次手术的移植物的百分比,以表征手术结果,进行生存分析,并在早期恢复手术可预测失败的情况下进行病例对照分析。方法:回顾性回顾了从单个外科医师收集的前瞻性数据。入组时间为2003年至2011年。记录返回手术室的患者人数和手术结果。计算了半月板移植存活曲线,移植与恢复至OR的持续时间以及围手术期需要再次手术者的失败风险比值比。结果:在研究期间,有200名患者接受了MAT。 38%被隔离; 62%的患者同时接受了手术。有64名(32%)患者返回手术室,其中38名(59%)患者是半月板患者?清创。二次手术的平均持续时间为21个月,其中2年内为73%。平均59个月(范围24-118个月)评估了一百七十二(86%)位患者。八名继续要求修订MAT或全膝关节置换(4.7%)。需要在两年内进行二次手术的患者未来失败的几率是8.4(95%CI 1.6-43.4 p.007)。结论:在文献报道的最大的连续系列研究中,半月板同种异体移植(MAT)成功率为95%,平均大约五年。再次手术率为32%,半月板清创术是最常见的二次手术治疗。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号